Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-28 @ 10:02 PM
Study NCT ID:
NCT06037460
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2023-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TocilizuMab discontinuAtion in GIant Cell Arteritis
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-07
First Submit QC Date:
None
Study First Post Date:
2023-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED